Adamis Pharmaceuticals (ADMP) Stock Is About To Hit New Low For 2021

Adamis Pharmaceuticals Corp (NASDAQ:ADMP) stock continues to be under pressure in the pre-market on Tuesday. Moreover, the stock is on the verge of hitting a new low for this year.

Adamis Pharmaceuticals (ADMP) Stock Is About To Hit New Low For 2021

At the time of writing, ADMP stock is down 17.33% to 62 cents, extending its yesterday’s fall of 7.37% There is no news for such a sharp fall. But, one should note that the stock has been very volatile since the beginning of this year.

Earlier this month, the stock soared almost 40% in one day on May 04th and hit $1.07. However, since then the stock has entered the downtrend and given up all its gains.

Related:  Stock to Watch: Inovio Pharmaceuticals, Inc (INO, NasdaqGS)

Last week, ADMP revealed that ZIMHITM announced that the New Drug Application (NDA) was resubmitted to the U.S. Food and Drug Administration (FDA) for ZIMHI™, a naloxone injection product candidate intended for the treatment of opioid overdose.

Keep an eye on ADMP stock if there will be any recovery.

Michael Rowels

Weekend Contributor. Writing for business and finance publishers has become his passion over the last decades after he completed a master's degree in Financial Management. Sharing some opinions and forecasts to thousands of readers is a routine job for him but he never promises to invest in one stock.